Skip to main content
$28.80 $1.73 (6.4%)

04:00 PM EST on 01/18/22

Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT)

CAPS Rating: No stars

The Company is a provider of management software for networks and applications. Its solutions address application performance management, capacity planning and design, network operations, and network research and development.

Current Price $28.80 Mkt Cap $135.9M
Open $26.69 P/E Ratio 79.46
Prev. Close $28.80 Div. (Yield) $0.00 (0.0%)
Daily Range $26.66 - $28.99 Volume 1
52-Wk Range $8.57 - $37.71 Avg. Daily Vol. 77,744

Caps

How do you think NASDAQ:OPNT will perform against the market?

Add Stock to CAPS Watchlist

All Players

124 Outperform
5 Underperform
 

All-Star Players

13 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:OPNT Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

cthuhlu (< 20)
Submitted November 29, 2021

OPNT is a specialty pharmaceutical company that has developed NARCAN and the U.S. Food and Drug Administration (“FDA”) has granted fast track designation for OPNT003, nasal nalmefene, the company's investigational treatment for opioid overdose. The… More

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

Recent Community Commentary

Read the most recent pitches from players about OPNT.

Recs

1
Member Avatar cthuhlu (< 20) Submitted: 11/29/2021 11:46:52 AM : Outperform Start Price: $25.27 NASDAQ:OPNT Score: +15.65

OPNT is a specialty pharmaceutical company that has developed NARCAN and the U.S. Food and Drug Administration (“FDA”) has granted fast track designation for OPNT003, nasal nalmefene, the company's investigational treatment for opioid overdose. The company could file a new drug application with the FDA as early as Q1 2022.

OPNT became profitable again in 2021 and their earning are forecast to grow more than 10% per year for the next 1 to 3 years.

Recs

1
Member Avatar rspenny (< 20) Submitted: 4/19/2020 12:13:15 PM : Outperform Start Price: $10.48 NASDAQ:OPNT Score: +113.14

Pharmaceuticals FDA approvals

Recs

1
Member Avatar kjmurphy15 (< 20) Submitted: 12/6/2010 5:01:33 PM : Outperform Start Price: $24.70 NASDAQ:OPNT Score: -251.73

No Debt, New Products, Leader, Increased Earnings

Leaderboard

Find the members with the highest scoring picks in OPNT.

Score Leader

eas6407

eas6407 (81.39) Score: +342.31

The Score Leader is the player with the highest score across all their picks in OPNT.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
SmallCapRoss < 20 1/17/2012 Underperform 5Y $34.05 -15.42% +250.95% +266.36 0 Comment
pademauge < 20 1/26/2021 Outperform 3M $9.39 +206.71% +18.45% +188.26 0 Comment
MancoraJack < 20 4/6/2021 Outperform 5Y $10.90 +164.22% +12.51% +151.71 0 Comment
rspenny < 20 4/20/2020 Outperform 5Y $10.48 +174.81% +61.67% +113.14 1 Comment
Guffrey < 20 2/26/2008 2/26/2008 Outperform 5Y $6.94 +315.16% +243.12% +72.04 0 Comment
jemoore567 < 20 3/25/2008 Outperform 3W $6.95 +314.11% +251.05% +63.06 0 Comment
davespics1 < 20 3/28/2008 Outperform 3M $7.20 +300.03% +255.99% +44.04 0 Comment
CrazyTrout < 20 11/14/2007 Outperform NS $7.92 +263.43% +220.52% +42.91 0 Comment
eblancafort 74.16 11/2/2007 Outperform NS $8.03 +258.68% +217.73% +40.95 0 Comment
tombreadman 95.60 10/22/2019 Outperform 5Y $15.44 +86.53% +51.87% +34.66 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for OPNT.